APO Research
Talk to an analyst

APO RESEARCH · REPORT

Valbenazine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Valbenazine Market Outlook and Growth Opportunities 2026

21 December 2025194 pages

Choose your research edition.

Industry ResearchValbenazine Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Valbenazine Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Valbenazine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Valbenazine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Valbenazine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Valbenazine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Valbenazine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Valbenazine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Valbenazine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Valbenazine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Valbenazine market include Vcare Pharmatech, Toronto Research Chemicals, TargetMol, Neurocrine Biosciences, Clearsynth, BOC Sciences and Adooq Bioscience, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Valbenazine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Valbenazine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Valbenazine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Valbenazine market size, projected growth trends, production technologies, key applications, and end-use industries.

Valbenazine Segment by Company

Vcare Pharmatech

Toronto Research Chemicals

TargetMol

Neurocrine Biosciences

Clearsynth

BOC Sciences

Adooq Bioscience

Valbenazine Segment by Type

40mg Capsule

60mg Capsule

80mg Capsule

Valbenazine Segment by Application

Tardive Dyskinesia

Tourette Syndrome

Valbenazine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Valbenazine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Valbenazine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Valbenazine significant trends, drivers, influence factors in global and regions.

6. To analyze Valbenazine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valbenazine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Valbenazine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valbenazine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Valbenazine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Valbenazine industry.

Chapter 3: Detailed analysis of Valbenazine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Valbenazine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Valbenazine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Valbenazine Industry Trends Table 2. Valbenazine Industry Drivers Table 3. Valbenazine Industry Opportunities and Challenges Table 4. Valbenazine Industry Restraints Table 5. Global Valbenazine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Valbenazine Revenue Share by Company (2021-2026) Table 7. Global Valbenazine Sales Volume by Company (k units) & (2021-2026) Table 8. Global Valbenazine Sales Volume Share by Company (2021-2026) Table 9. Global Valbenazine Average Price (US$/unit) of Company (2021-2026) Table 10. Global Valbenazine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Valbenazine Key Company Manufacturing Base & Headquarters Table 12. Global Valbenazine Company, Product Type & Application Table 13. Global Valbenazine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Valbenazine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 40mg Capsule Table 18. Significant Companies of 60mg Capsule Table 19. Significant Companies of 80mg Capsule Table 20. Global Valbenazine Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Valbenazine Sales Volume by Type (2021-2026) & (k units) Table 22. Global Valbenazine Sales Volume by Type (2027-2032) & (k units) Table 23. Global Valbenazine Sales Volume Share by Type (2021-2026) Table 24. Global Valbenazine Sales Volume Share by Type (2027-2032) Table 25. Global Valbenazine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Valbenazine Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Valbenazine Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Valbenazine Sales Value Share by Type (2021-2026) Table 29. Global Valbenazine Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Tardive Dyskinesia Table 31. Significant Companies of Tourette Syndrome Table 32. Global Valbenazine Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Valbenazine Sales Volume by Application (2021-2026) & (k units) Table 34. Global Valbenazine Sales Volume by Application (2027-2032) & (k units) Table 35. Global Valbenazine Sales Volume Share by Application (2021-2026) Table 36. Global Valbenazine Sales Volume Share by Application (2027-2032) Table 37. Global Valbenazine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Valbenazine Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Valbenazine Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Valbenazine Sales Value Share by Application (2021-2026) Table 41. Global Valbenazine Sales Value Share by Application (2027-2032) Table 42. Global Valbenazine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Valbenazine Sales by Region (2021-2026) & (k units) Table 44. Global Valbenazine Sales Market Share by Region (2021-2026) Table 45. Global Valbenazine Sales by Region (2027-2032) & (k units) Table 46. Global Valbenazine Sales Market Share by Region (2027-2032) Table 47. Global Valbenazine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Valbenazine Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Valbenazine Sales Value Share by Region (2021-2026) Table 50. Global Valbenazine Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Valbenazine Sales Value Share by Region (2027-2032) Table 52. Global Valbenazine Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Valbenazine Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Valbenazine Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Valbenazine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Valbenazine Sales by Country (2021-2026) & (k units) Table 57. Global Valbenazine Sales Market Share by Country (2021-2026) Table 58. Global Valbenazine Sales by Country (2027-2032) & (k units) Table 59. Global Valbenazine Sales Market Share by Country (2027-2032) Table 60. Global Valbenazine Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Valbenazine Sales Value Market Share by Country (2021-2026) Table 62. Global Valbenazine Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Valbenazine Sales Value Market Share by Country (2027-2032) Table 64. Vcare Pharmatech Company Information Table 65. Vcare Pharmatech Business Overview Table 66. Vcare Pharmatech Valbenazine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Vcare Pharmatech Valbenazine Product Portfolio Table 68. Vcare Pharmatech Recent Development Table 69. Toronto Research Chemicals Company Information Table 70. Toronto Research Chemicals Business Overview Table 71. Toronto Research Chemicals Valbenazine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Toronto Research Chemicals Valbenazine Product Portfolio Table 73. Toronto Research Chemicals Recent Development Table 74. TargetMol Company Information Table 75. TargetMol Business Overview Table 76. TargetMol Valbenazine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. TargetMol Valbenazine Product Portfolio Table 78. TargetMol Recent Development Table 79. Neurocrine Biosciences Company Information Table 80. Neurocrine Biosciences Business Overview Table 81. Neurocrine Biosciences Valbenazine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Neurocrine Biosciences Valbenazine Product Portfolio Table 83. Neurocrine Biosciences Recent Development Table 84. Clearsynth Company Information Table 85. Clearsynth Business Overview Table 86. Clearsynth Valbenazine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Clearsynth Valbenazine Product Portfolio Table 88. Clearsynth Recent Development Table 89. BOC Sciences Company Information Table 90. BOC Sciences Business Overview Table 91. BOC Sciences Valbenazine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. BOC Sciences Valbenazine Product Portfolio Table 93. BOC Sciences Recent Development Table 94. Adooq Bioscience Company Information Table 95. Adooq Bioscience Business Overview Table 96. Adooq Bioscience Valbenazine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Adooq Bioscience Valbenazine Product Portfolio Table 98. Adooq Bioscience Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Valbenazine Distributors List Table 102. Valbenazine Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Valbenazine Product Image Figure 2. Global Valbenazine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Valbenazine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Valbenazine Sales (2021-2032) & (k units) Figure 5. Global Valbenazine Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Valbenazine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 40mg Capsule Image Figure 10. 60mg Capsule Image Figure 11. 80mg Capsule Image Figure 12. Global Valbenazine Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Valbenazine Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Valbenazine Sales Volume Share by Type (2021-2032) Figure 15. Global Valbenazine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Valbenazine Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Valbenazine Sales Value Share by Type (2021-2032) Figure 18. Tardive Dyskinesia Image Figure 19. Tourette Syndrome Image Figure 20. Global Valbenazine Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Valbenazine Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Valbenazine Sales Volume Share by Application (2021-2032) Figure 23. Global Valbenazine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Valbenazine Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Valbenazine Sales Value Share by Application (2021-2032) Figure 26. Global Valbenazine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Valbenazine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Valbenazine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Valbenazine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Valbenazine Sales Value (2021-2032) & (US$ Million) Figure 31. North America Valbenazine Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Valbenazine Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Valbenazine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Valbenazine Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Valbenazine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Valbenazine Sales Value (2021-2032) & (US$ Million) Figure 37. South America Valbenazine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Valbenazine Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Valbenazine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Valbenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Valbenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Valbenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Valbenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Valbenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Valbenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Valbenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Valbenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Valbenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Valbenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Valbenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Valbenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Valbenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Valbenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Valbenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Valbenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Valbenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Valbenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Valbenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Valbenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Valbenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Valbenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Valbenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Valbenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Valbenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Valbenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Valbenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Valbenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Valbenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Valbenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Valbenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Valbenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Valbenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Valbenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Valbenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Valbenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Valbenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Valbenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Valbenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Valbenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Valbenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Valbenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Valbenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Valbenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Valbenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Valbenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Valbenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Valbenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Valbenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Valbenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Valbenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Valbenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Valbenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Valbenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Valbenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Valbenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Valbenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Valbenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Valbenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Valbenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Valbenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Valbenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Valbenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Valbenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Valbenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Valbenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Valbenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Valbenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Valbenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Valbenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Valbenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Valbenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Valbenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Valbenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Valbenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Valbenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Valbenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Valbenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Valbenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Valbenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Valbenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Valbenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Valbenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Valbenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Valbenazine Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Valbenazine Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 40mg Capsule
  • 60mg Capsule
  • 80mg Capsule
Applications
  • Tardive Dyskinesia
  • Tourette Syndrome
Companies covered
  • Vcare Pharmatech
  • Toronto Research Chemicals
  • TargetMol
  • Neurocrine Biosciences
  • Clearsynth
  • BOC Sciences
  • Adooq Bioscience

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Valbenazine Sales Value (2021-2032)
  4. 1.2.2 Global Valbenazine Sales Volume (2021-2032)
  5. 1.2.3 Global Valbenazine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Valbenazine Market Dynamics
  1. 2.1 Valbenazine Industry Trends
  2. 2.2 Valbenazine Industry Drivers
  3. 2.3 Valbenazine Industry Opportunities and Challenges
  4. 2.4 Valbenazine Industry Restraints
3 Valbenazine Market by Company
  1. 3.1 Global Valbenazine Company Revenue Ranking in 2025
  2. 3.2 Global Valbenazine Revenue by Company (2021-2026)
  3. 3.3 Global Valbenazine Sales Volume by Company (2021-2026)
  4. 3.4 Global Valbenazine Average Price by Company (2021-2026)
  5. 3.5 Global Valbenazine Company Ranking (2024-2026)
  6. 3.6 Global Valbenazine Company Manufacturing Base and Headquarters
  7. 3.7 Global Valbenazine Company Product Type and Application
  8. 3.8 Global Valbenazine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Valbenazine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Valbenazine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Valbenazine Market by Type
  1. 4.1 Valbenazine Type Introduction
  2. 4.1.1 40mg Capsule
  3. 4.1.2 60mg Capsule
  4. 4.1.3 80mg Capsule
  5. 4.2 Global Valbenazine Sales Volume by Type
  6. 4.2.1 Global Valbenazine Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Valbenazine Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Valbenazine Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Valbenazine Sales Value by Type
  10. 4.3.1 Global Valbenazine Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Valbenazine Sales Value by Type (2021-2032)
  12. 4.3.3 Global Valbenazine Sales Value Share by Type (2021-2032)
5 Valbenazine Market by Application
  1. 5.1 Valbenazine Application Introduction
  2. 5.1.1 Tardive Dyskinesia
  3. 5.1.2 Tourette Syndrome
  4. 5.2 Global Valbenazine Sales Volume by Application
  5. 5.2.1 Global Valbenazine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Valbenazine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Valbenazine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Valbenazine Sales Value by Application
  9. 5.3.1 Global Valbenazine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Valbenazine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Valbenazine Sales Value Share by Application (2021-2032)
6 Valbenazine Regional Sales and Value Analysis
  1. 6.1 Global Valbenazine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Valbenazine Sales by Region (2021-2032)
  3. 6.2.1 Global Valbenazine Sales by Region: 2021-2026
  4. 6.2.2 Global Valbenazine Sales by Region (2027-2032)
  5. 6.3 Global Valbenazine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Valbenazine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Valbenazine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Valbenazine Sales Value by Region (2027-2032)
  9. 6.5 Global Valbenazine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Valbenazine Sales Value (2021-2032)
  12. 6.6.2 North America Valbenazine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Valbenazine Sales Value (2021-2032)
  15. 6.7.2 Europe Valbenazine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Valbenazine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Valbenazine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Valbenazine Sales Value (2021-2032)
  21. 6.9.2 South America Valbenazine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Valbenazine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Valbenazine Sales Value Share by Country, 2025 VS 2032
7 Valbenazine Country-level Sales and Value Analysis
  1. 7.1 Global Valbenazine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Valbenazine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Valbenazine Sales by Country (2021-2032)
  4. 7.3.1 Global Valbenazine Sales by Country (2021-2026)
  5. 7.3.2 Global Valbenazine Sales by Country (2027-2032)
  6. 7.4 Global Valbenazine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Valbenazine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Valbenazine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Valbenazine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Valbenazine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Valbenazine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Valbenazine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Valbenazine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Valbenazine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Valbenazine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Valbenazine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Valbenazine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Valbenazine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Valbenazine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Valbenazine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Valbenazine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Valbenazine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Valbenazine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Valbenazine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Valbenazine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Valbenazine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Valbenazine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Valbenazine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Valbenazine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Valbenazine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Valbenazine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Valbenazine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Valbenazine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Valbenazine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Valbenazine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Valbenazine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Valbenazine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Valbenazine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Valbenazine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Valbenazine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Valbenazine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Valbenazine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Valbenazine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Valbenazine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Valbenazine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Valbenazine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Valbenazine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Valbenazine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Valbenazine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Valbenazine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Valbenazine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Valbenazine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Valbenazine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Valbenazine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Valbenazine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Valbenazine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Valbenazine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Valbenazine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Valbenazine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Valbenazine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Valbenazine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Valbenazine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Valbenazine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Valbenazine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Valbenazine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Valbenazine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Valbenazine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Valbenazine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Valbenazine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Valbenazine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Valbenazine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Valbenazine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Valbenazine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Valbenazine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Valbenazine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Valbenazine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Valbenazine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Valbenazine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Valbenazine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Valbenazine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Valbenazine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Valbenazine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Valbenazine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Valbenazine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Valbenazine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Valbenazine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Valbenazine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Valbenazine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Valbenazine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Valbenazine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Valbenazine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Valbenazine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Vcare Pharmatech
  2. 8.1.1 Vcare Pharmatech Company Information
  3. 8.1.2 Vcare Pharmatech Business Overview
  4. 8.1.3 Vcare Pharmatech Valbenazine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Vcare Pharmatech Valbenazine Product Portfolio
  6. 8.1.5 Vcare Pharmatech Recent Developments
  7. 8.2 Toronto Research Chemicals
  8. 8.2.1 Toronto Research Chemicals Company Information
  9. 8.2.2 Toronto Research Chemicals Business Overview
  10. 8.2.3 Toronto Research Chemicals Valbenazine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Toronto Research Chemicals Valbenazine Product Portfolio
  12. 8.2.5 Toronto Research Chemicals Recent Developments
  13. 8.3 TargetMol
  14. 8.3.1 TargetMol Company Information
  15. 8.3.2 TargetMol Business Overview
  16. 8.3.3 TargetMol Valbenazine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 TargetMol Valbenazine Product Portfolio
  18. 8.3.5 TargetMol Recent Developments
  19. 8.4 Neurocrine Biosciences
  20. 8.4.1 Neurocrine Biosciences Company Information
  21. 8.4.2 Neurocrine Biosciences Business Overview
  22. 8.4.3 Neurocrine Biosciences Valbenazine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Neurocrine Biosciences Valbenazine Product Portfolio
  24. 8.4.5 Neurocrine Biosciences Recent Developments
  25. 8.5 Clearsynth
  26. 8.5.1 Clearsynth Company Information
  27. 8.5.2 Clearsynth Business Overview
  28. 8.5.3 Clearsynth Valbenazine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Clearsynth Valbenazine Product Portfolio
  30. 8.5.5 Clearsynth Recent Developments
  31. 8.6 BOC Sciences
  32. 8.6.1 BOC Sciences Company Information
  33. 8.6.2 BOC Sciences Business Overview
  34. 8.6.3 BOC Sciences Valbenazine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 BOC Sciences Valbenazine Product Portfolio
  36. 8.6.5 BOC Sciences Recent Developments
  37. 8.7 Adooq Bioscience
  38. 8.7.1 Adooq Bioscience Company Information
  39. 8.7.2 Adooq Bioscience Business Overview
  40. 8.7.3 Adooq Bioscience Valbenazine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Adooq Bioscience Valbenazine Product Portfolio
  42. 8.7.5 Adooq Bioscience Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Valbenazine Value Chain Analysis
  2. 9.1.1 Valbenazine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Valbenazine Sales Mode & Process
  6. 9.2 Valbenazine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Valbenazine Distributors
  9. 9.2.3 Valbenazine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst